# NEW HEALTH SCIENCES, INC.: Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | NEW HEALTH SCIENCES, INC. |
| Location | Lexington, MA |
| Project | Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia |
| Project number | 5R44HL178006-02 |
| Mechanism | R44 |
| Institute | National Heart Lung and Blood Institute |
| Award | $984,232 |
| Awarded | 2026-09-04 |
| Project period | 2025-09-05 to 2028-08-31 |
| UEI | CC3QRDB7EYX7 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11415142). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.